Literature DB >> 3038085

The rapid desensitization of glucagon-stimulated adenylate cyclase is a cyclic AMP-independent process that can be mimicked by hormones which stimulate inositol phospholipid metabolism.

G J Murphy, V J Hruby, D Trivedi, M J Wakelam, M D Houslay.   

Abstract

Treatment of intact hepatocytes with glucagon, TH-glucagon [( 1-N-alpha-trinitrophenylhistidine, 12-homoarginine]glucagon), angiotensin or vasopressin led to a rapid time- and dose-dependent loss of the glucagon-stimulated response of the adenylate cyclase activity seen in membrane fractions isolated from these cells. Intracellular cyclic AMP concentrations were only elevated with glucagon. All ligands were capable of causing both desensitization/loss of glucagon-stimulated adenylate cyclase activity and stimulation of inositol phospholipid metabolism in the intact hepatocytes. Maximally effective doses of angiotensin precluded any further inhibition/desensitizing action when either glucagon or TH-glucagon was subsequently added to these intact cells, as has been shown previously for the phorbol ester TPA (12-O-tetradecanoylphorbol 13-acetate) [Heyworth, Wilson, Gawler & Houslay (1985) FEBS Lett. 187, 196-200]. Treatment of intact hepatocytes with these various ligands caused a selective loss of the glucagon-stimulated adenylate cyclase activity in a washed membrane fraction and did not alter the basal, GTP-, NaF- and forskolin-stimulated responses. Angiotensin failed to inhibit glucagon-stimulated adenylate cyclase activity when added directly to a washed membrane fraction from control cells. Glucagon GR2 receptor-stimulated adenylate cyclase is suggested to undergo desensitization/uncoupling through a cyclic AMP-independent process, which involves the stimulation of inositol phospholipid metabolism by glucagon acting through GR1 receptors. This action can be mimicked by other hormones which act on the liver to stimulate inositol phospholipid metabolism. As the phorbol ester TPA also mimics this process, it is proposed that protein kinase C activation plays a pivotal role in the molecular mechanism of desensitization of glucagon-stimulated adenylate cyclase. The site of the lesion in desensitization is shown to be at the level of coupling between the glucagon receptor and the stimulatory guanine nucleotide regulatory protein Gs, and it is suggested that one or both of these components may provide a target for phosphorylation by protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3038085      PMCID: PMC1147811          DOI: 10.1042/bj2430039

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Nalpha-trinitrophenyl glucagon: an inhibitor of glucagon-stimulated cyclic AMP production and its effects on glycogenolysis.

Authors:  T E Cote; R M Epand
Journal:  Biochim Biophys Acta       Date:  1979-01-18

2.  Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme.

Authors:  P E Stanley; S G Williams
Journal:  Anal Biochem       Date:  1969-06       Impact factor: 3.365

3.  Direct evidence of a glucagon-dependent regulation of the concentration of glucagon receptors in the liver.

Authors:  A Santos; E Blazquez
Journal:  Eur J Biochem       Date:  1982-01

4.  Guanosine 5'-triphosphate and guanosine 5'-[beta gamma-imido]triphosphate effect a collision coupling mechanism between the glucagon receptor and catalytic unit of adenylate cyclase.

Authors:  M D Houslay; I Dipple; K R Elliott
Journal:  Biochem J       Date:  1980-03-15       Impact factor: 3.857

5.  Cholera toxin mediated activation of adenylate cyclase in intact rat hepatocytes.

Authors:  M D Houslay; K R Elliott
Journal:  FEBS Lett       Date:  1979-08-15       Impact factor: 4.124

6.  The glucagon receptor of rat liver plasma membrane can couple to adenylate cyclase without activating it.

Authors:  M D Houslay; J C Metcalfe; G B Warren; T R Hesketh; G A Smith
Journal:  Biochim Biophys Acta       Date:  1976-06-17

7.  Differential effects of tryptophan on glucose synthesis in rats and guinea pigs.

Authors:  S A Smith; K R Elliott; C I Pogson
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

8.  Glucagon amino groups. Evaluation of modifications leading to antagonism and agonism.

Authors:  M D Bregman; D Trivedi; V J Hruby
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

9.  Effect of lutropin and cycloheximide on lutropin receptors and cyclic AMP production in Leydig tumour cells in vitro.

Authors:  C J Dix; B A Cooke
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

10.  The phorbol ester TPA inhibits cyclic AMP phosphodiesterase activity in intact hepatocytes.

Authors:  F Irvine; N J Pyne; M D Houslay
Journal:  FEBS Lett       Date:  1986-11-24       Impact factor: 4.124

View more
  20 in total

1.  Differential short-term desensitization to vasopressin, isoproterenol, glucagon, parathyroid hormone and calcitonin in the thick ascending limb of rat kidney.

Authors:  I Dublineau; P Pradelles; C de Rouffignac; J M Elalouf
Journal:  Pflugers Arch       Date:  1992-01       Impact factor: 3.657

2.  Dual mode of glucagon receptor internalization: role of PKCα, GRKs and β-arrestins.

Authors:  Lada Krilov; Amy Nguyen; Teruo Miyazaki; Cecilia G Unson; Russell Williams; Norman H Lee; Susan Ceryak; Bernard Bouscarel
Journal:  Exp Cell Res       Date:  2011-10-06       Impact factor: 3.905

3.  Glucagon, vasopressin and angiotensin all elicit a rapid, transient increase in hepatocyte protein kinase C activity.

Authors:  E K Tang; M D Houslay
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

4.  A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes.

Authors:  A Savage; L Zeng; M D Houslay
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

5.  Glucagon and p21 ras enhance the phosphorylation of the same 38-kilodalton membrane protein from rat liver cells.

Authors:  A N Hegde; M R Das
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 6.  Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.

Authors:  Victor J Hruby; Minying Cai
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013       Impact factor: 13.820

7.  Resensitization of hepatocyte glucagon-stimulated adenylate cyclase can be inhibited when cyclic AMP phosphodiesterase inhibitors are used to elevate intracellular cyclic AMP concentrations to supraphysiological values.

Authors:  G J Murphy; M D Houslay
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

8.  Co-transfection with protein kinase D confers phorbol-ester-mediated inhibition on glucagon-stimulated cAMP accumulation in COS cells transfected to overexpress glucagon receptors.

Authors:  E S Tobias; E Rozengurt; J M Connell; M D Houslay
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

9.  High-fat diet-induced hepatic steatosis reduces glucagon receptor content in rat hepatocytes: potential interaction with acute exercise.

Authors:  Alexandre Charbonneau; Cecilia G Unson; Jean-Marc Lavoie
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

10.  PKC stimulated by glucagon decreases UT-A1 urea transporter expression in rat IMCD.

Authors:  Yuristella Yano; Adilson C Rodrígues; Ana C de Bragança; Lucia C Andrade; Antonio J Magaldi
Journal:  Pflugers Arch       Date:  2008-05-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.